Discovery - University of Dundee - Online Publications

Library & Learning Centre

Deep Resequencing Unveils Genetic Architecture of ADIPOQ and Identifies a Novel Low-Frequency Variant Strongly Associated With Adiponectin Variation

Standard

Deep Resequencing Unveils Genetic Architecture of ADIPOQ and Identifies a Novel Low-Frequency Variant Strongly Associated With Adiponectin Variation. / Warren, Liling L.; Li, Li; Nelson, Matthew R.; Ehm, Margaret G.; Shen, Judong; Fraser, Dana J.; Aponte, Jennifer L.; Nangle, Keith L.; Slater, Andrew J.; Woollard, Peter M.; Hall, Matt D.; Topp, Simon D.; Yuan, Xin; Cardon, Lon R.; Chissoe, Stephanie L.; Mooser, Vincent; Morris, Andrew D.; Palmer, Colin N. A.; Perry, John R.; Frayling, Timothy M.; Whittaker, John C.; Waterworth, Dawn M.

In: Diabetes, Vol. 61, No. 5, 05.2012, p. 1297-1301.

Research output: Contribution to journalArticle

Harvard

Warren, LL, Li, L, Nelson, MR, Ehm, MG, Shen, J, Fraser, DJ, Aponte, JL, Nangle, KL, Slater, AJ, Woollard, PM, Hall, MD, Topp, SD, Yuan, X, Cardon, LR, Chissoe, SL, Mooser, V, Morris, AD, Palmer, CNA, Perry, JR, Frayling, TM, Whittaker, JC & Waterworth, DM 2012, 'Deep Resequencing Unveils Genetic Architecture of ADIPOQ and Identifies a Novel Low-Frequency Variant Strongly Associated With Adiponectin Variation' Diabetes, vol 61, no. 5, pp. 1297-1301., 10.2337/db11-0985

APA

Warren, L. L., Li, L., Nelson, M. R., Ehm, M. G., Shen, J., Fraser, D. J., ... Waterworth, D. M. (2012). Deep Resequencing Unveils Genetic Architecture of ADIPOQ and Identifies a Novel Low-Frequency Variant Strongly Associated With Adiponectin Variation. Diabetes, 61(5), 1297-1301. 10.2337/db11-0985

Vancouver

Warren LL, Li L, Nelson MR, Ehm MG, Shen J, Fraser DJ et al. Deep Resequencing Unveils Genetic Architecture of ADIPOQ and Identifies a Novel Low-Frequency Variant Strongly Associated With Adiponectin Variation. Diabetes. 2012 May;61(5):1297-1301. Available from: 10.2337/db11-0985

Author

Warren, Liling L.; Li, Li; Nelson, Matthew R.; Ehm, Margaret G.; Shen, Judong; Fraser, Dana J.; Aponte, Jennifer L.; Nangle, Keith L.; Slater, Andrew J.; Woollard, Peter M.; Hall, Matt D.; Topp, Simon D.; Yuan, Xin; Cardon, Lon R.; Chissoe, Stephanie L.; Mooser, Vincent; Morris, Andrew D.; Palmer, Colin N. A.; Perry, John R.; Frayling, Timothy M.; Whittaker, John C.; Waterworth, Dawn M. / Deep Resequencing Unveils Genetic Architecture of ADIPOQ and Identifies a Novel Low-Frequency Variant Strongly Associated With Adiponectin Variation.

In: Diabetes, Vol. 61, No. 5, 05.2012, p. 1297-1301.

Research output: Contribution to journalArticle

Bibtex - Download

@article{aaf61ad148a44abd8baa35980b078615,
title = "Deep Resequencing Unveils Genetic Architecture of ADIPOQ and Identifies a Novel Low-Frequency Variant Strongly Associated With Adiponectin Variation",
author = "Warren, {Liling L.} and Li Li and Nelson, {Matthew R.} and Ehm, {Margaret G.} and Judong Shen and Fraser, {Dana J.} and Aponte, {Jennifer L.} and Nangle, {Keith L.} and Slater, {Andrew J.} and Woollard, {Peter M.} and Hall, {Matt D.} and Topp, {Simon D.} and Xin Yuan and Cardon, {Lon R.} and Chissoe, {Stephanie L.} and Vincent Mooser and Morris, {Andrew D.} and Palmer, {Colin N. A.} and Perry, {John R.} and Frayling, {Timothy M.} and Whittaker, {John C.} and Waterworth, {Dawn M.}",
year = "2012",
doi = "10.2337/db11-0985",
volume = "61",
number = "5",
pages = "1297--1301",
journal = "Diabetes",
issn = "0012-1797",

}

RIS (suitable for import to EndNote) - Download

TY - JOUR

T1 - Deep Resequencing Unveils Genetic Architecture of ADIPOQ and Identifies a Novel Low-Frequency Variant Strongly Associated With Adiponectin Variation

A1 - Warren,Liling L.

A1 - Li,Li

A1 - Nelson,Matthew R.

A1 - Ehm,Margaret G.

A1 - Shen,Judong

A1 - Fraser,Dana J.

A1 - Aponte,Jennifer L.

A1 - Nangle,Keith L.

A1 - Slater,Andrew J.

A1 - Woollard,Peter M.

A1 - Hall,Matt D.

A1 - Topp,Simon D.

A1 - Yuan,Xin

A1 - Cardon,Lon R.

A1 - Chissoe,Stephanie L.

A1 - Mooser,Vincent

A1 - Morris,Andrew D.

A1 - Palmer,Colin N. A.

A1 - Perry,John R.

A1 - Frayling,Timothy M.

A1 - Whittaker,John C.

A1 - Waterworth,Dawn M.

AU - Warren,Liling L.

AU - Li,Li

AU - Nelson,Matthew R.

AU - Ehm,Margaret G.

AU - Shen,Judong

AU - Fraser,Dana J.

AU - Aponte,Jennifer L.

AU - Nangle,Keith L.

AU - Slater,Andrew J.

AU - Woollard,Peter M.

AU - Hall,Matt D.

AU - Topp,Simon D.

AU - Yuan,Xin

AU - Cardon,Lon R.

AU - Chissoe,Stephanie L.

AU - Mooser,Vincent

AU - Morris,Andrew D.

AU - Palmer,Colin N. A.

AU - Perry,John R.

AU - Frayling,Timothy M.

AU - Whittaker,John C.

AU - Waterworth,Dawn M.

PY - 2012/5

Y1 - 2012/5

N2 - <p>Increased adiponectin levels have been shown to be associated with a lower risk of type 2 diabetes. To understand the relations between genetic variation at the adiponectin-encoding gene, ADIPOQ, and adiponectin levels, and subsequently its role in disease, we conducted a deep resequencing experiment of ADIPOQ in 14,002 subjects, including 12,514 Europeans, 594 African Americans, and 567 Indian Asians. We identified 296 single nucleotide polymorphisms (SNPs), including 30 amino acid changes, and carried out association analyses in a subset of 3,665 subjects from two independent studies. We confirmed multiple genome-wide association study findings and identified a novel association between a low-frequency SNP (rs17366653) and adiponectin levels (P = 2.2E-17). We show that seven SNPs exert independent effects on adiponectin levels. Together, they explained 6% of adiponectin variation in our samples. We subsequently assessed association between these SNPs and type 2 diabetes in the Genetics of Diabetes Audit and Research in Tayside Scotland (GO-DARTS) study, comprised of 5,145 case and 6,374 control subjects. No evidence of association with type 2 diabetes was found, but we were also unable to exclude the possibility of substantial effects (e.g., odds ratio 95% CI for rs7366653 [0.91-1.58]). Further investigation by large-scale and well-powered Mendelian randomization studies is warranted. Diabetes 61:1297-1301, 2012</p>

AB - <p>Increased adiponectin levels have been shown to be associated with a lower risk of type 2 diabetes. To understand the relations between genetic variation at the adiponectin-encoding gene, ADIPOQ, and adiponectin levels, and subsequently its role in disease, we conducted a deep resequencing experiment of ADIPOQ in 14,002 subjects, including 12,514 Europeans, 594 African Americans, and 567 Indian Asians. We identified 296 single nucleotide polymorphisms (SNPs), including 30 amino acid changes, and carried out association analyses in a subset of 3,665 subjects from two independent studies. We confirmed multiple genome-wide association study findings and identified a novel association between a low-frequency SNP (rs17366653) and adiponectin levels (P = 2.2E-17). We show that seven SNPs exert independent effects on adiponectin levels. Together, they explained 6% of adiponectin variation in our samples. We subsequently assessed association between these SNPs and type 2 diabetes in the Genetics of Diabetes Audit and Research in Tayside Scotland (GO-DARTS) study, comprised of 5,145 case and 6,374 control subjects. No evidence of association with type 2 diabetes was found, but we were also unable to exclude the possibility of substantial effects (e.g., odds ratio 95% CI for rs7366653 [0.91-1.58]). Further investigation by large-scale and well-powered Mendelian randomization studies is warranted. Diabetes 61:1297-1301, 2012</p>

U2 - 10.2337/db11-0985

DO - 10.2337/db11-0985

M1 - Article

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 5

VL - 61

SP - 1297

EP - 1301

ER -

Documents

Library & Learning Centre

Contact | Accessibility | Policy